- Home
- SBGI vs PSNL Comparison
SBGI vs PSNL Comparison
Compare SBGI & PSNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBGI
- PSNL
- Stock Information
- Founded
- SBGI 1986
- PSNL 2011
- Country
- SBGI United States
- PSNL United States
- Employees
- SBGI N/A
- PSNL N/A
- Industry
- SBGI Broadcasting
- PSNL Medical Specialities
- Sector
- SBGI Industrials
- PSNL Health Care
- Exchange
- SBGI Nasdaq
- PSNL Nasdaq
- Market Cap
- SBGI 886.6M
- PSNL 854.8M
- IPO Year
- SBGI 1995
- PSNL 2019
- Fundamental
- Price
- SBGI $15.92
- PSNL $11.05
- Analyst Decision
- SBGI Buy
- PSNL Strong Buy
- Analyst Count
- SBGI 5
- PSNL 7
- Target Price
- SBGI $21.00
- PSNL $10.43
- AVG Volume (30 Days)
- SBGI 595.5K
- PSNL 1.7M
- Earning Date
- SBGI 11-05-2025
- PSNL 11-04-2025
- Dividend Yield
- SBGI 6.34%
- PSNL N/A
- EPS Growth
- SBGI N/A
- PSNL N/A
- EPS
- SBGI N/A
- PSNL N/A
- Revenue
- SBGI $3,337,000,000.00
- PSNL $69,103,000.00
- Revenue This Year
- SBGI N/A
- PSNL N/A
- Revenue Next Year
- SBGI $9.50
- PSNL $29.83
- P/E Ratio
- SBGI N/A
- PSNL N/A
- Revenue Growth
- SBGI N/A
- PSNL N/A
- 52 Week Low
- SBGI $11.89
- PSNL $2.83
- 52 Week High
- SBGI $18.46
- PSNL $11.20
- Technical
- Relative Strength Index (RSI)
- SBGI 55.53
- PSNL 70.15
- Support Level
- SBGI $14.52
- PSNL $7.11
- Resistance Level
- SBGI $17.88
- PSNL $9.89
- Average True Range (ATR)
- SBGI 0.88
- PSNL 0.92
- MACD
- SBGI -0.07
- PSNL 0.26
- Stochastic Oscillator
- SBGI 40.96
- PSNL 99.78
About SBGI Sinclair Inc.
Sinclair Inc. is the owner-operator of the second largest portfolio of television stations in the United States, with 185 full power stations in 86 markets, covering 40% of US households. Of the firm's roughly 600 channels, 150 are affiliated with the four national broadcasters—Fox, ABC, CBS, and NBC—with over 80 other channels aligned with The CW (Nexstar) and MyNetworkTV (Fox). Sinclair owns the Tennis Channel and stakes in Marquee Sports Network and YES Network, providing their premium sports content to pay-TV distributors.
About PSNL Personalis Inc.
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.